title: Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation.
authors.affiliation: Clinica Chirurgica IV, Department of Medical and Surgical Sciences, Ospedale Giustinianeo, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: Rigotti
authors.forename: N
authors.initials: N
authors.lastname: Baldan
authors.forename: R
authors.initials: R
authors.lastname: Cadrobbi
authors.forename: L
authors.initials: L
authors.lastname: Furian
authors.forename: G
authors.initials: G
authors.lastname: Sarzo
authors.forename: L
authors.initials: L
authors.lastname: Dall'Olmo
authors.forename: E
authors.initials: E
authors.lastname: Ancona
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008875:Middle Aged; D016035:Pancreas Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016559:Tacrolimus